Unknown

Dataset Information

0

AKT activation controls cell survival in response to HDAC6 inhibition.


ABSTRACT: HDAC6 is emerging as an important therapeutic target for cancer. We investigated mechanisms responsible for survival of tumor cells treated with a HDAC6 inhibitor. Expression of the 20?000 genes examined did not change following HDAC6 treatment in vivo. We found that HDAC6 inhibition led to an increase of AKT activation (P-AKT) in vitro, and genetic knockdown of HDAC6 phenocopied drug-induced AKT activation. The activation of AKT was not observed in PTEN null cells; otherwise, PTEN/PIK3CA expression per se did not predict HDAC6 inhibitor sensitivity. Interestingly, HDAC6 inhibitor treatment led to inactivating phosphorylation of PTEN (P-PTEN Ser380), which likely led to the increased P-AKT in cells that express PTEN. Synergy was observed with phosphatidylinositol 3'-kinases (PI3K) inhibitor treatment in vitro, accompanied by increased caspase 3/7 activity. Furthermore, combination of HDAC6 inhibitor with a PI3K inhibitor caused substantial tumor growth inhibition in vivo compared with either treatment alone, also detectable by Ki-67 immunostaining and (18)F-FLT positron emission tomography (PET). In aggregate AKT activation appears to be a key survival mechanism for HDAC6 inhibitor treatment. Our findings indicate that dual inhibition of HDAC6 and P-AKT may be necessary to substantially inhibit growth of solid tumors.

SUBMITTER: Kaliszczak M 

PROVIDER: S-EPMC5108334 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

AKT activation controls cell survival in response to HDAC6 inhibition.

Kaliszczak M M   Trousil S S   Ali T T   Aboagye E O EO  

Cell death & disease 20160630 6


HDAC6 is emerging as an important therapeutic target for cancer. We investigated mechanisms responsible for survival of tumor cells treated with a HDAC6 inhibitor. Expression of the 20 000 genes examined did not change following HDAC6 treatment in vivo. We found that HDAC6 inhibition led to an increase of AKT activation (P-AKT) in vitro, and genetic knockdown of HDAC6 phenocopied drug-induced AKT activation. The activation of AKT was not observed in PTEN null cells; otherwise, PTEN/PIK3CA expres  ...[more]

Similar Datasets

| S-EPMC4639856 | biostudies-literature
| S-EPMC4707053 | biostudies-literature
2015-12-09 | E-GEOD-71901 | biostudies-arrayexpress
2015-12-09 | E-GEOD-71900 | biostudies-arrayexpress
2015-12-09 | E-GEOD-71898 | biostudies-arrayexpress
2015-12-09 | GSE71901 | GEO
| S-EPMC3003005 | biostudies-literature
| S-EPMC4263459 | biostudies-literature
| S-EPMC4063670 | biostudies-literature
| PRJNA292415 | ENA